1996
- (NIAID) Important Therapeutic Information on the Dosing of Clarithromycin for the Treatment of Disseminated Mycobacterium avium Complex (DMAC) Infection in HIV-Infected Patients
- Office of Communications, National Institute of Allergy and Infectious Disease - July 23, 1995
- (NIAID) Two New Protease Inhibitors Approved by FDA: NIAID research was pivotal to development of new class of drugs
- Office of Communications, National Institute of Allergy and Infectious Disease - March, 1996
This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1995. ÆGIS.